MARKET WIREYahoo Finance • 21h ago
What Makes SINTX TECHNOLOGIES (SINT) a New Buy StockYahoo Finance report covering SiNtx Technologies Inc. (SINT) market action, institutional positioning, and fundamental catalysts.
Why SINT Stock advanced +0.59% Today — RQD Quant Desk Flash
$1.71 +0.59% NASDAQ • Live Quote vs Prior Daily Close (Synced Snapshot)
EXT / AFTER-HRS: $1.71
SiNtx Technologies Inc. (SINT) carries a Roarable Rating of E (Strong Sell) with 33/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.
ROARABLE E • RED ALERT
Cap $12.8M
⚡ INSTANT AI QUANT PREVIEW • $0 FREE TIER
Click Any Pre-Computed AI Quant Specialist Briefing on SINT Below — or Connect Your Own ChatGPT / Claude
🤖 Mara Quenwick • AI Quant Lead (Click for Instant Brief)
Is SINT stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
▼
As of 2026-11-03, SiNtx Technologies Inc. (NASDAQ: SINT) is rated E (Strong Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 33/100 at a spot price of $1.71 (+0.59% 1D, market cap $12.8M). Pillar breakdown: Fundamental Cash Engine 7/20, Institutional 13F & Options Flow 4/20, SEC Balance-Sheet Forensics 11/20, FRED Macro Regime Fit 6/20, and Executive Insider Alignment 5/20. Across 1015 tracked Health Care issuers, SINT ranks #699 in composite RQD confidence.
✓ Pre-computed one-to-many AI Quant brief
🤖 Ellis Vennor • AI Peer & Flow Quant (Click for Instant Brief)
How does SINT compare to CNSY and GUTS in the Health Care sector?
▼
Within the Health Care sector (Medical/Dental Instruments), SINT carries a Roarable E (33/100 RQD), trailing P/E of N/A, gross margin of 45.3%, and ROIC of -35.0%. By comparison, CNSY (Cerenome Inc.) holds a E grade (25/100 RQD, P/E N/A, ROIC -35.0%, cap $12.9M) and GUTS (Fractyl Health Inc.) posts a E grade (34/100 RQD, P/E N/A, ROIC -35.0%, cap $13.0M). Among the 5-stock peer group, SINT leads on earnings multiple (N/A) while SINT leads on capital efficiency (-35.0% ROIC).
✓ Pre-computed one-to-many AI Quant brief
🤖 Gideon Ashmere • AI SEC 10-K Forensics (Click for Instant Brief)
What are the biggest fundamental strengths and SEC risk factors for SINT?
▼
Per SINT's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001269026), SiNtx Technologies Inc. generated $1.0M in revenue (-64.7% YoY), -$10.4M in net income, and -$8.8M in free cash flow against $9.5M in total assets and $0 in total debt. Key quantitative strengths: Established market leader in Health Care with deep daily trading liquidity. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately. Institutional options positioning shows a 50% call / 50% put premium split.
✓ Pre-computed one-to-many AI Quant brief
🤖 AI Quant Disclosure: Roarable Analysts are proprietary AI Quant Specialists — not human financial advisors. Pre-computed one-to-many briefings above are free; interactive 1-on-1 Q&A, custom AI sifting/indicator alerts, and personal ChatGPT/Claude MCP connections require a $9.95/mo Pro account (currently waitlist-only).
INTERACTIVE SCENARIO DECK:
EXT / AFTER-HRS: $1.71 (-0.08%)🧬 Disciplined Float (+0.72% YoY Shares)⚙️ Cash Engine: 7/20 (D-) • 0% FCF Margin
Verify 90D Bucket Audit →📊 Historical Track Record Warning: Scores below 50 (33/100 · E) historically underperformed SPY in 71% of rolling 90-day windows (-8.9% avg 90D alpha vs SPY • 29.0% hit rate).
Audit Bucket Track Record →RQD QUANT TACHOMETERRED ALERT • E
2-of-3 JEV AI Jury Bearish Warning
Cash
SEC
Whale
Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer
5-PILLAR SNOWFLAKE RADARRw E · Rk D-
Each axis scored 0–20
12M PRICE TARGET CONE-11.1% Base Target
WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for SINT)Realized 20D OHLCV Swing Band: ±12.5%
Deterministic 5-Pillar Attribution (33/100 Composite)
🔍 WHY SINT SCORES 33/100 (E) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag
▲ #1 Bullish Driver: SEC 10-K Forensic Risk+11/20 pts (33% of score)
Altman Z-Score 3.80 (FORTRESS SAFE (>3.0)) • Piotroski F-Score 4/9
▲ #2 Bullish Driver: Cash Engine Quality+7/20 pts (21% of score)
SEC XBRL FY 2025 (10-K): 0% FCF Margin ($0 FCF) & 45.3% Gross Margin
▼ #1 Drag / Risk Factor: Whale & Options Positioning4/20 pts (-16 pt drag)
Put hedging (50% put share) caps near-term gamma upside (-16 pts vs max)
📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current
Q1 (-3Q)Grade D$2.07-16.9% Next Q
41
Q2 (-2Q)Grade E$1.72-0.6% Next Q
38
Q3 (-1Q)Grade E$1.71+0% Next Q
36
CurrentGrade E$1.71-8.9% Hist 90D α
33
Trajectory: D (41) → E (33)Full Audit →
⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)CONTRARIAN TURNAROUND & SHORT-SQUEEZE DOSSIER
⚔️ Adversarial Opposing Case: What Could Spark a SINT Turnaround Squeeze
While SINT currently carries a cautious 33/100 (E) rating due to Whale & Options Positioning (4/20), shorts face asymmetric squeeze risk if free cash flow inflects or management executes accretive buybacks.
🚀 Contrarian Squeeze Trigger #1
Established market leader in Health Care with deep daily trading liquidity.
🚀 Contrarian Squeeze Trigger #2
Options & Short-Covering Gamma: Reclaiming the 50-day SMA ($1.80) and Max Pain ($1.80) forces dealer call-delta covering toward $4.68.
🚀 Contrarian Squeeze Trigger #3
Forensic Repair Trigger: Halting share dilution (Disciplined Float (+0.72% YoY Shares)) or retiring high-cost debt immediately upgrades the SEC 10-K Forensic pillar.
🎲 LIVE PREDICTION MARKET ODDS TIED TO $SINT• $2.4M Crowd Pool • Kalshi / Polymarket Composite
Contract: “SINT Beats Next Quarter EPS Consensus (Dec 30, 2026) & Holds Above 200D SMA”
AUTOMATED RQD QUANT DESK MOVER BRIEFINGFull Market News Desk →
Why SINT Stock advanced +0.59% Today — RQD Quant Desk Flash
SiNtx Technologies Inc. (SINT) advanced +0.59% to $1.71, trading at 10% of its 52-week range ($1.4 – $4.46). Stretched risk/reward at current multiples (-35% return on capital) under elevated 10-year interest-rate pressure.
- ▸Technical Tape: Trading at 10% of its 52-week range ($1.4 – $4.46) with RSI-14 at 43.4 (NEUTRAL RANGE).
- ▸Volatility Profile: Historical 20-day realized swing band of ±12.5% around $1.71 (no active unusual options sweep snapshot on file).
- ▸Fundamental Anchor: Roarable E (Strong Sell) backed by 45.3% gross margin and $0 annual free cash flow.
Live SINT Headlines & Catalysts
MARKET WIRETradingView • 1d ago
SINTX Technologies nets $2.01M from Class B warrant call, issues 651,204 sharesTradingView report covering SiNtx Technologies Inc. (SINT) market action, institutional positioning, and fundamental catalysts.
MARKET WIREGlobeNewswire • 1d ago
SINTX Technologies Announces Third Quarter 2026 Earnings Release Date and WebcastGlobeNewswire report covering SiNtx Technologies Inc. (SINT) market action, institutional positioning, and fundamental catalysts.
MARKET WIRETradingView • 1d ago
SINT Q3'26 Earnings: revenue estimate is 1.33M USDTradingView report covering SiNtx Technologies Inc. (SINT) market action, institutional positioning, and fundamental catalysts.
MARKET WIREhttps://www.siam.in/ • 1d ago
SiNtx Technologies (SINT) Climbs 3.48% to $1.64 as Shares Press Toward Resistance - PCR Divergencehttps://www.siam.in/ report covering SiNtx Technologies Inc. (SINT) market action, institutional positioning, and fundamental catalysts.
MARKET WIRETradingKey • 1d ago
Unusual Volume Stocks & Volume Spikes TodayTradingKey report covering SiNtx Technologies Inc. (SINT) market action, institutional positioning, and fundamental catalysts.
MARKET WIRETradingKey • 1d ago
High Dividend Yield Stocks for IncomeTradingKey report covering SiNtx Technologies Inc. (SINT) market action, institutional positioning, and fundamental catalysts.
MARKET WIREBenzinga • 20d ago
Transcript: SINTX Technologies Q2 2026 Earnings Conference CallSINTX Technologies (NASDAQ:SINT) held its second-quarter earnings conference call on Tuesday. Below is the complete transcript from the call. This transcript is brought to you by Benzinga APIs. For real-time access to
ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk
Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring SINT)
- ✓Walkthrough of SINT's RQD Radar, SEC cash-conversion gap & downside invalidation levels
- ✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
- ✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks
RQD INSIDER CLUB WAITLIST$49/YR PLANNED
Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?
SINT // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: -29.34%📐 WEDGE COMPRESSION COIL
2026-11-03O $1.72H $1.72L $1.70C $1.71VOL 4.7K
RES: $2.37SUP: $1.56SMA50: $1.80SMA200: $2.21
PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK
SINT Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure
Share Count & Dilution Monitor
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
Reverse-DCF Expectations Hurdle
8.0%/yr Implied 5Y Growth
vs. -64.7% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
Ellis Vennor Setup Ledger
No active Ellis Vennor swing setup published on SINT today. View full Setup Ledger →
🦋 Documented & Second-Order Butterfly Connections
Open Graph →
No direct multi-tier Butterfly edges indexed yet for SINT. Explore sector supply chains on /butterfly.
AI Analyst Theses, Washington Policy & Company Video
🎬 No recent verified company-specific video clip queued for SINT today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →
DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK
📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (SINT)
Health Care Rank #699 of 1015
⚔️ CNSY vs SINT Full Matrix →
1. Head-to-Head Health Care Peer Comparison (SINT vs. CNSY, GUTS, ICU, CTSO)
Industry: Medical/Dental Instruments (120 Tracked Issuers)Across 1015 tracked Health Care securities in the Roarable RQD universe, SiNtx Technologies Inc. (SINT) ranks #699 by composite RQD confidence (33/100, grade E) and #867 by equity capitalization ($12.8M). Within this direct 5-issuer industry benchmark cohort, SINT leads on earnings valuation at N/A trailing P/E, while SINT leads on capital efficiency and profitability with -35.0% ROIC and 45.3% gross margin. GUTS currently holds the highest overall quantitative score in the immediate peer group at 34/100 (E) compared with SINT at 33/100 (E).
| Ticker / Company | Roarable Grade | RQD Score | Trailing P/E | Gross Margin | ROIC | 1D Change | Market Cap | Head-to-Head |
|---|---|---|---|---|---|---|---|---|
| SINT
ACTIVE
SiNtx Technologies Inc. | E | 33/100 | — | 45.3% | -35.0% | +0.59% | $12.8M | Benchmark Subject |
| CNSY Cerenome Inc. | E | 25/100 | — | — | -35.0% | +0.59% | $12.9M | /cnsy-vs-sint → |
| GUTS Fractyl Health Inc. | E | 34/100 | — | — | -35.0% | -3.47% | $13.0M | /guts-vs-sint → |
| ICU SeaStar Medical Holding Corporation | E | 31/100 | — | 95.7% | -35.0% | -2.23% | $11.8M | /icu-vs-sint → |
| CTSO Cytosorbents Corporation | E | 22/100 | — | 71.5% | -35.0% | -9.25% | $14.3M | /ctso-vs-sint → |
2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)
SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0001269026 ↗In its most recent audited fiscal period (FY2025, filed 2025-12-31), SiNtx Technologies Inc. (SINT) reported GAAP revenue of $1.0M (-64.7% vs. FY2024 revenue of $2.9M , and -61.2% cumulative change since FY2023) , GAAP net income of -$10.4M, operating cash flow of -$8.6M, and free cash flow of -$8.8M (+6.2% YoY). On the balance sheet, SINT closed FY2025 with $9.5M in total assets against $0 in total debt (Altman Z-Score: N/A, Piotroski F-Score: 4/9).
| Fiscal Period | Filing Date | Revenue | Net Income | Operating Cash Flow | Free Cash Flow | Total Assets | Total Debt |
|---|---|---|---|---|---|---|---|
| FY2025 (FY) | 2025-12-31 | $1.0M | -$10.4M | -$8.6M | -$8.8M | $9.5M | — |
| FY2024 (FY) | 2024-12-31 | $2.9M | -$11.0M | -$8.6M | -$9.3M | $9.4M | — |
| FY2023 (FY) | 2023-12-31 | $2.6M | -$8.3M | -$14.1M | -$14.1M | — | — |
3. SINT Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)
✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLEDIs SINT stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
As of 2026-11-03, SiNtx Technologies Inc. (NASDAQ: SINT) is rated E (Strong Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 33/100 at a spot price of $1.71 (+0.59% 1D, market cap $12.8M). Pillar breakdown: Fundamental Cash Engine 7/20, Institutional 13F & Options Flow 4/20, SEC Balance-Sheet Forensics 11/20, FRED Macro Regime Fit 6/20, and Executive Insider Alignment 5/20. Across 1015 tracked Health Care issuers, SINT ranks #699 in composite RQD confidence.
How does SINT compare to CNSY and GUTS in the Health Care sector?
Within the Health Care sector (Medical/Dental Instruments), SINT carries a Roarable E (33/100 RQD), trailing P/E of N/A, gross margin of 45.3%, and ROIC of -35.0%. By comparison, CNSY (Cerenome Inc.) holds a E grade (25/100 RQD, P/E N/A, ROIC -35.0%, cap $12.9M) and GUTS (Fractyl Health Inc.) posts a E grade (34/100 RQD, P/E N/A, ROIC -35.0%, cap $13.0M). Among the 5-stock peer group, SINT leads on earnings multiple (N/A) while SINT leads on capital efficiency (-35.0% ROIC).
What are the biggest fundamental strengths and SEC risk factors for SINT?
Per SINT's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001269026), SiNtx Technologies Inc. generated $1.0M in revenue (-64.7% YoY), -$10.4M in net income, and -$8.8M in free cash flow against $9.5M in total assets and $0 in total debt. Key quantitative strengths: Established market leader in Health Care with deep daily trading liquidity. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately. Institutional options positioning shows a 50% call / 50% put premium split.
Where is SINT trading relative to its 50-day, 200-day, and 52-week technical levels?
SINT last traded at $1.71 (+0.59% on volume of 11,866 shares), positioning the stock -5.00% below its 50-day simple moving average ($1.80) and -22.62% below its 200-day simple moving average ($2.21). Across its 52-week range of $1.40 to $4.46, SINT sits at the 10.1% percentile with a 14-day RSI of 43.4 (NEUTRAL RANGE) and an implied next-earnings move of ±12.5% ($1.50 to $1.92).
ROARABLE RATING BRIEF • RQD 33/100 (E)
✓ SEC XBRL & RQD VERIFIED
SINT — SiNtx Technologies Inc.: What the Facts Mean to a Prospective Investor
Methodology: RQD v6.2 Deterministic 5-Pillar & SEC XBRL Audit
Updated: 2025-12-31
1. Roarable Rating Brief: What This Means to a Prospective Investor
SiNtx Technologies Inc. (SINT) earns a live Roarable RQD composite score of 33/100, corresponding to a E letter grade (Roarable Strong Sell) at a spot price of $1.71 (+0.59% 1D, market capitalization $12.8M).
- Fundamental Cash Engine (7/20): Anchored by return on invested capital (ROIC) of -35.0%, gross margin of 45.3%, operating margin of -60.0%, and free cash flow yield of —.
- Whale 13F & Options Flow (4/20) + Insider Conviction (5/20): Tracks institutional 13F accumulation, CBOE options call/put positioning, and SEC Form 4 / Congressional PTR filings.
- Macro Regime Fit (6/20) + Forensic Balance Sheet (11/20): Incorporates a 1.00x equity beta, Altman Z-Score of N/A, Piotroski F-Score of 4/9, and Debt/Equity of N/A.
2. Business Model, Unit Margins & SEC Financial Trajectory
SiNtx Technologies Inc. (SINT) is a NASDAQ-listed issuer classified under the Health Care sector and Medical/Dental Instruments industry. Reported revenue across the three fiscal years in the SEC financials ranges from $1.0M to $2.9M, and the company reports a gross margin of 45.3% per the market data.
In its latest audited SEC EDGAR 10-K filing for FY2025 (filed 2025-12-31), SiNtx Technologies Inc. (SINT) reported $1.0M in annual revenue (up from $2.9M in FY2024, -64.7% YoY) and -$10.4M in GAAP net income. Over the multi-year SEC filing window from FY2023 ($2.6M revenue, -$8.3M net income) through FY2025, SINT scaled operating cash flow to -$8.6M and free cash flow to -$8.8M, backed by $9.5M in total assets against $0 in total debt.
3. Institutional Bull vs. Bear Thesis & Valuation Tradeoff
- 🐂 Primary Bull Case (E • RQD 33/100): Established market leader in Health Care with deep daily trading liquidity. Free cash flow yield of — and institutional whale pillar of 4/20. With Fundamental Cash Engine at 7/20 and Institutional Whale Flow at 4/20, sustained execution supports upside toward the upper end of the $1.40 – $4.46 52-week range.
- 🐻 Primary Bear Case & Valuation Risk: Company executives have done more routine share selling than personal cash buying lately. Investors must weigh current valuation against -60.0% operating margins and a 1.00x macro beta.
4. 2nd-Order Butterfly Ripples & Key Questions to Watch
Upstream and downstream dependencies, sector correlations, and second-order bottlenecks are therefore — Investors should note that the absence of mapped links means this analysis cannot identify ripple effects from suppliers, customers, or peer issuers.
- Key Question #1: Can SINT sustain or expand its -60.0% operating margin and -35.0% ROIC against Medical/Dental Instruments peers over the next 4 quarters?
- Key Question #2: Following FY2025 revenue of $1.0M and free cash flow of -$8.8M, how will capital allocation balance growth reinvestment against $0 in total debt?
- Key Question #3: How sensitive is SINT's equity valuation to Health Care capital spending cycles and macro interest-rate shifts (Beta 1.00x)?
SINT Live News Feed, Press Releases & Catalyst Wire
Real-time company headlines, analyst actions, and sector developments for SiNtx Technologies Inc. (SINT) • Click "Debate This Headline" to argue it in the Roar Pit below
🟡 MARKET WIRE Yahoo Finance • 21h ago
What Makes SINTX TECHNOLOGIES (SINT) a New Buy Stock Yahoo Finance report covering SiNtx Technologies Inc. (SINT) market action, institutional positioning, and fundamental catalysts.
🟡 MARKET WIRE TradingView • 1d ago
SINTX Technologies nets $2.01M from Class B warrant call, issues 651,204 shares TradingView report covering SiNtx Technologies Inc. (SINT) market action, institutional positioning, and fundamental catalysts.
🟡 MARKET WIRE GlobeNewswire • 1d ago
SINTX Technologies Announces Third Quarter 2026 Earnings Release Date and Webcast GlobeNewswire report covering SiNtx Technologies Inc. (SINT) market action, institutional positioning, and fundamental catalysts.
🟡 MARKET WIRE TradingView • 1d ago
SINT Q3'26 Earnings: revenue estimate is 1.33M USD TradingView report covering SiNtx Technologies Inc. (SINT) market action, institutional positioning, and fundamental catalysts.
🟡 MARKET WIRE https://www.siam.in/ • 1d ago
SiNtx Technologies (SINT) Climbs 3.48% to $1.64 as Shares Press Toward Resistance - PCR Divergence https://www.siam.in/ report covering SiNtx Technologies Inc. (SINT) market action, institutional positioning, and fundamental catalysts.
🟡 MARKET WIRE TradingKey • 1d ago
Unusual Volume Stocks & Volume Spikes Today TradingKey report covering SiNtx Technologies Inc. (SINT) market action, institutional positioning, and fundamental catalysts.
🟡 MARKET WIRE TradingKey • 1d ago
High Dividend Yield Stocks for Income TradingKey report covering SiNtx Technologies Inc. (SINT) market action, institutional positioning, and fundamental catalysts.
🟡 MARKET WIRE Benzinga • 20d ago
Transcript: SINTX Technologies Q2 2026 Earnings Conference Call SINTX Technologies (NASDAQ:SINT) held its second-quarter earnings conference call on Tuesday. Below is the complete transcript from the call. This transcript is brought to you by Benzinga APIs. For real-time access to
🔥 THE ROAR PIT • LIVE COMMUNITY DEBATE
3 Active Posts & Replies
SINT Bull vs. Bear Conversation Board — What's Your Call at $1.71?
🐂 67% BULLISH CONVICTION COMMUNITY TUG-OF-WAR ON SINT 🐻 33% BEARISH CONVICTION
MI MidwestValue RQD DEBATE OPENER • Fundamental Long-Only 🐂 BULLISH
🎯 Target: $2.12 (+24.7%)
📌 Pinned Debate Balance sheet pillar scores 11/20 with an Altman Z of 2.5 and Debt/Equity of 0.5, the strongest component of the RQD rating.
Don't sleep on SINT's setup in Health Care. Balance sheet pillar scores 11/20 with an Altman Z of 2.5 and Debt/Equity of 0.5, the strongest component of the RQD rating.. Beta of 1.0 means it moves fast when momentum turns, and the 5-pillar RQD gauge (33/100) backs up the fundamental quality.
CapAlloc_Nerd 🐂 BULL
@RiskArb_Desk Fair point on current EV/EBITDA multiples, but you're ignoring the forward operating leverage in Medical/Dental Instruments. If gross margin (45.3%) holds, EPS grows into the multiple faster than bears think.
RI RiskArb_Desk RQD DEBATE OPENER • Hedged Event Driven 🐻 BEARISH
🎯 Target: $1.31 (-22.9%)
Spot @ $1.70 ROIC of -35%, a 0% FCF yield, and FY 2025 revenue down to $1.0M from $2.9M show no current cash generation.
I respect the product at SiNtx Technologies Inc., but the stock at $1.70 is a different story. ROIC of -35%, a 0% FCF yield, and FY 2025 revenue down to $1.0M from $2.9M show no current cash generation.. FCF yield is 0.0% and RQD sits at 33/100 (E) — why pay up here when you can wait for next quarter's numbers?